Early neuroaxonal injury is seen in the acute phase of pediatric optic neuritis.

[1]  Jerry L Prince,et al.  Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning , 2020, Multiple sclerosis.

[2]  M. Bach,et al.  Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis? , 2019, Neurology: Neuroimmunology & Neuroinflammation.

[3]  Fiona Costello,et al.  Retinal imaging with optical coherence tomography: a biomarker in multiple sclerosis? , 2018, Eye and brain.

[4]  Xinghuai Sun,et al.  Clinical Characteristics of Pediatric Optic Neuritis With Myelin Oligodendrocyte Glycoprotein Seropositive: A Cohort Study. , 2018, Pediatric neurology.

[5]  T. Frohman,et al.  New Ways of “Seeing” the Mechanistic Heterogeneity of Multiple Sclerosis Plaque Pathogenesis , 2018, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[6]  I. Zubizarreta,et al.  Early retinal atrophy predicts long-term visual impairment after acute optic neuritis , 2017, Multiple sclerosis.

[7]  Alexander Klistorner,et al.  Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis , 2017, The Lancet Neurology.

[8]  T. Aleman,et al.  Optical coherence tomography and visual evoked potentials in pediatric MS , 2017, Neurology: Neuroimmunology & Neuroinflammation.

[9]  E. Waubant,et al.  Sex differences and subclinical retinal injury in pediatric-onset MS , 2017, Multiple sclerosis.

[10]  Bernhard Hemmer,et al.  Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination , 2016, Multiple sclerosis.

[11]  R. Kardon,et al.  Retinal ganglion cell layer thinning within one month of presentation for optic neuritis , 2016, Multiple sclerosis.

[12]  K. Rostásy,et al.  Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[13]  A. Traboulsee,et al.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders , 2015, Neurology.

[14]  K. Fujihara,et al.  MOG cell-based assay detects non-MS patients with inflammatory neurologic disease , 2015, Neurology: Neuroimmunology & Neuroinflammation.

[15]  I. Zubizarreta,et al.  Dynamics of retinal injury after acute optic neuritis , 2015, Annals of neurology.

[16]  R. Kardon,et al.  The temporal evolution of structural and functional measures after acute optic neuritis , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[17]  G. Plant,et al.  Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria , 2015, Multiple sclerosis.

[18]  B. Banwell,et al.  Functional–structural correlations in the afferent visual pathway in pediatric demyelination , 2014, Neurology.

[19]  John S Werner,et al.  Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability. , 2014, Investigative ophthalmology & visual science.

[20]  B. Weinshenker,et al.  Evaluation of aquaporin‐4 antibody assays , 2014, Clinical & experimental neuroimmunology.

[21]  H. Goltz,et al.  Measuring contrast sensitivity using the M&S Smart System II versus the Pelli-Robson chart. , 2013, Ophthalmology.

[22]  A. Ghezzi,et al.  International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions , 2013, Multiple sclerosis.

[23]  D. Goodin,et al.  Retinal Axonal Loss Begins Early in the Course of Multiple Sclerosis and Is Similar between Progressive Phenotypes , 2012, PloS one.

[24]  Axel Petzold,et al.  The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment , 2012, PloS one.

[25]  W. Feuer,et al.  Macular ganglion cell-inner plexiform layer: automated detection and thickness reproducibility with spectral domain-optical coherence tomography in glaucoma. , 2011, Investigative ophthalmology & visual science.

[26]  R. Kardon,et al.  Baseline, one and three month changes in the peripapillary retinal nerve fiber layer in acute optic neuritis: Relation to baseline vision and MRI , 2011, Journal of the Neurological Sciences.

[27]  P. Munot,et al.  Childhood optic neuritis clinical features and outcome , 2010, Archives of Disease in Childhood.

[28]  T. Nakazawa,et al.  Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.

[29]  M. Ramanathan,et al.  Retinal nerve fiber thickness in inflammatory demyelinating diseases of childhood onset , 2009, Multiple sclerosis.

[30]  S. Galetta,et al.  Pediatric optic neuritis , 2009, Neurology.

[31]  D. Arnold,et al.  Incidence of acquired demyelination of the CNS in Canadian children , 2009, Neurology.

[32]  B. Banwell,et al.  The clinical features, MRI findings, and outcome of optic neuritis in children , 2006, Neurology.

[33]  F. Hanefeld,et al.  Pediatric multiple sclerosis: detection of clinically silent lesions by multimodal evoked potentials. , 2006, The Journal of pediatrics.

[34]  R. Kardon,et al.  Quantifying axonal loss after optic neuritis with optical coherence tomography , 2006 .

[35]  R A Saunders,et al.  The amblyopia treatment study visual acuity testing protocol. , 2001, Archives of ophthalmology.

[36]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[37]  F. Ferris,et al.  New visual acuity charts for clinical research. , 1982, American journal of ophthalmology.